The present study investigated the effect of the probiotic strain Enterococcus faecium DSM 7134 (2 x 10(7) cfu per g of feed) (probiotic group), natural humic substances (7g x kg(-1) feed) (HS group), and the combination of both (probiotic + HS group) on the performance, serum biochemistry, and biological activity of leucocytes of broiler chickens. Average body weight of chickens in different phases as well as throughout the observation period under different treatments did not differ significantly. Final body weight and feed conversion ratio (FCR) reached in 41 days of trial were 2542.5; 2568.9; 2610.5, 2516.6 g and 1.93; 1.81; 1.78; 1.88 kg for HS, probiotic, probiotic + HS and control group respectively. The best performance variables including the European efficiency index (EEI) were observed in the probiotic + HS group, where the effect of the probiotic supplementation was improved by HS. There were no significant differences among groups in the serum levels of total protein, glucose, cholesterol, aminotransferase and phosphorus. A significant decrease of total lipids in the probiotic group (P < 0.01) and probiotic + HS group (P < 0.001) groups, triglycerides levels in the HS (P < 0.01), probiotic and probiotic + HS (P < 0.001) groups on day 35, calcium level of the probiotic (P < 0.05) and probiotic + HS (P < 0.01) groups on day 41 and alkaline phosphatase levels in the probiotic group (P < 0.01) on day 14 were observed in comparison to the control group. Significantly higher values of indices of metabolic activity of phagocytes (IMA) after 14, 35 and 41 days of the experiment were observed in the probiotic + HS group (P < 0.01, P < 0.05) when compared with the control group. No adverse health effects were observed in experimental groups The results of the present study indicate that HS and E. faecium DSM 7134 had no significant effect on performance. However an improvement in FCR and EEI was observed which is believed to be due to the significant increase of indices of metabolic activity of phagocytes, caused by HS when combined with. E. faecium DSM 7134.
Download full-text PDF |
Source |
---|
Res Child Adolesc Psychopathol
January 2025
Nutrition and Mental Health Research Group (NUTRISAM), Universitat Rovira I Virgili (URV), Carretera de Valls, S/N, 43007, Tarragona, Spain.
The aim of this study is to investigate the impact of using probiotics with strains related to dopamine and gamma-aminobutyric acid production on clinical features of autism spectrum disorder (ASD) and/or attention deficit/hyperactivity disorder (ADHD). This randomized, controlled trial involved 38 children with ADHD and 42 children with ASD, aged 5-16 years, who received probiotics (Lactiplantibacillus plantarum and Levilactobacillus brevis 109/cfu/daily) or placebo for 12 weeks. Parent-reported symptoms were assessed using Conners' 3rd-Ed and the Social Responsiveness Scale Test, 2nd-Ed (SRS-2), and children completed the Conners Continuous Performance Test, 3rd-Ed (CPT 3) or Conners Kiddie CPT, 2nd-Ed (K-CPT 2).
View Article and Find Full Text PDFJ Clin Med
January 2025
Department of Affective and Psychotic Disorders, Medical University of Lodz, 92-216 Lodz, Poland.
: Depression often coexists with anemia, potentially sharing common pathways, highlighting the need for treatments addressing both conditions simultaneously. This study evaluated the effect of probiotics on red blood cell (RBC) parameters in adults with depressive disorder. We hypothesized that probiotics would positively influence RBC parameters, potentially modulated by baseline inflammation or dietary intake, with improved RBC function correlating with better antidepressant outcomes.
View Article and Find Full Text PDFJ Clin Med
December 2024
Health, Nutrition & Care, DSM-Firmenich, 4303 Kaiseraugst, Switzerland.
Biotics are increasingly being used in the treatment of irritable bowel syndrome (IBS). This study aimed to assess the efficacy and safety of a mixture of microencapsulated sodium butyrate, probiotics ( DSM 26357, DSM 32418, DSM 32946, DSM 32403, and DSM 32269), and short-chain fructooligosaccharides (scFOSs) in IBS patients. This was a randomized, double-blind, placebo-controlled trial involving 120 adult participants with IBS.
View Article and Find Full Text PDFNutrients
December 2024
Nihonbashi Cardiology Clinic, Kyodo Bldg. #201, 13-4 Nihonbashi Kodenmacho, Chuo-ku, Tokyo 103-0001, Japan.
Background/objectives: GCL1815 is a lactic acid bacterium thought to activate dendritic cells. This randomized, placebo-controlled, double-blind study aimed to evaluate the effects of GCL1815 on human dendritic cells and the onset of the common cold.
Methods: Two hundred participants were divided into two groups and took capsules containing either six billion GCL1815 cells or placebo for 8 weeks.
Foods
January 2025
Departament of Biology, University of Lavras (UFLA)-Campus Universitário, Lavras 37200-900, MG, Brazil.
Canastra cheese, an artisanal cheese produced in Serra da Canastra-Brazil, has great cultural importance. Furthermore, this cheese has nutritional and sensory attributes that make it of great economic importance. Its microbiota is composed of different bacteria and yeasts.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!